Regional Intelligence Command Center
Real-time denial patterns, payer intelligence, and contract negotiation data across US markets
National Avg Denial Rate
21.6%
Across all payers & categories
Avg Appeal Overturn
26.7%
Successful reversals on appeal
Highest Denial State
VA
28.2% denial rate
Most Favorable State
IL
15.3% denial rate
Market Overview — State-Level Denial Rates
| State | Region | Denial Rate | Trend | Overturn Rate | Avg Resolution Days | Top Denial Reason |
|---|---|---|---|---|---|---|
| CA | West | 16% | 2.4% | 15.2% | 51 days | Failed Prior Authorization |
| TX | South | 22.2% | 9.1% | 36.7% | 37 days | Not Medically Necessary |
| FL | South | 19.9% | 0.5% | 16.5% | 36 days | Failed Step Therapy |
| NY | Northeast | 21.4% | 10.6% | 16.4% | 47 days | Not Medically Necessary |
| PA | Northeast | 23.1% | 8.1% | 17.6% | 31 days | Out of Network Provider |
| IL | Midwest | 15.3% | 7.9% | 35% | 56 days | Out of Network Provider |
| OH | Midwest | 17.9% | 0.1% | 17.3% | 25 days | Lack of Clinical Justification |
| GA | South | 21.9% | 9.8% | 34% | 32 days | Failed Step Therapy |
| NC | South | 20.4% | 2.5% | 32.5% | 38 days | Experimental Treatment |
| MI | Midwest | 18.8% | 3.3% | 30% | 30 days | Failed Prior Authorization |
| NJ | Northeast | 24.2% | 7.6% | 32.6% | 58 days | Coding Error / Bundling Issue |
| VA | South | 28.2% | 1.3% | 38.9% | 35 days | Experimental Treatment |
| WA | West | 27.9% | 15.8% | 39.7% | 39 days | Lack of Clinical Justification |
| AZ | West | 26.5% | 12.4% | 17.8% | 43 days | Lack of Clinical Justification |
| MA | Northeast | 20.2% | 7.5% | 20.5% | 33 days | Insufficient Medical Documentation |
Payer Comparison Matrix — Denial Rates by CPT Category
| Payer | Imaging Denial Rate | Market Share | 6M Trend | Total Claims | Comparative Position |
|---|---|---|---|---|---|
| UnitedHealthcare | 25.0% | 3.8% | ↓ 3.7% | 16,543 | Stricter than avg |
| Anthem BCBS | 25.5% | 17.1% | ↓ 2.0% | 7,234 | Stricter than avg |
| Aetna | 27.4% | 7.6% | ↑ 7.8% | 15,724 | Stricter than avg |
| Cigna | 26.5% | 16.2% | ↑ 3.0% | 18,963 | Stricter than avg |
| Humana | 14.6% | 12.3% | ↓ 8.2% | 8,684 | More lenient than avg |
| Blue Cross | 26.0% | 9.8% | ↓ 1.7% | 10,632 | Stricter than avg |
| State Medicaid | 13.3% | 17.4% | ↑ 1.6% | 16,542 | More lenient than avg |
| Medicare (CMS) | 24.0% | 10.9% | ↑ 11.2% | 7,488 | Stricter than avg |
Plan-Level Intelligence
Drill into specific health plans for detailed denial metrics and appeal strategies
UnitedHealthcare Plan 1
UnitedHealthcare
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
UnitedHealthcare Plan 2
UnitedHealthcare
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Anthem BCBS Plan 1
Anthem BCBS
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Anthem BCBS Plan 2
Anthem BCBS
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Aetna Plan 1
Aetna
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Aetna Plan 2
Aetna
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Regional Policy Changes & Trending Alerts
UnitedHealthcare Imaging Denial Surge
Imaging denials increased 8.3% YoY. New prior auth requirements effective March 2026.
Anthem Step Therapy Expansion
Anthem expanding step therapy to infusion/biologics. Biologic approvals require 8-week conventional trial.
Medicaid Approval Trend Positive
State Medicaid programs showing 3.2% improvement in appeal overturn rates.
Contract Negotiation Ammunition
Data-backed negotiation talking points by payer
UnitedHealthcare — Imaging Overreach
- • Imaging denial rate: 24.3% (national avg: 21.6%)
- • YoY increase: +8.3% — highest among major competitors
- • Appeal overturn rate: 18.2% suggests denials not clinically justified
- • Benchmark: Aetna imaging denials at 16.7%, demonstrating more rational approach
Anthem — Overly Aggressive Step Therapy
- • Infusion/biologic denial rate: 28.5% (payer avg: 18.3%)
- • New 8-week conventional therapy requirement adds 40+ days to approval
- • Blue Cross plan competing on your network approves at 14.2% denial rate
- • Consider network reduction penalty clause in RFP response
Regional Opportunity — Texas/FL Markets
- • Texas denial rate: 14.2% (lowest in South region)
- • Florida Medicaid: 22.8% denial rate but 32% appeal overturn
- • Negotiation lever: "Your denial rates trailing regional peers by 6.1%"
- • Opportunity: Volume rebates if deny rate improves to regional median
Benchmark Comparison — Appeal Economics
- • National appeal success rate: 26.7%
- • High-denial payers (>20%) showing appeal success of 25%+
- • Cost to hospitals: $500-1,000 per appeal dispute
- • Propose: Monthly denial reconciliation calls to reduce appeals by 30%
Network Performance Benchmarks
How your hospital network compares to regional peers
Your Network (Simulated)
16.2%
Overall denial rate
Regional Peer Average
18.4%
200-300 bed hospitals, same region
Best-in-Class Benchmark
11.8%
Top 10% of networks nationally
Position: Your denial rate is 2.2 percentage points better than regional peers. With targeted clinical documentation improvements, best-in-class position is achievable within 6 months. This translates to ~$280K in recovered revenue annually based on current claim volume.